BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Allergy to pollen, Retina, Biofuel, Phenobarbital, rs6983267, FXYD4)
Bookmark Forward

QuickView for LKP (gene)


Body Atlas

Most Correlated Tissues

  1. Granulocyte-macrophage progenitor cell of bone marrow
  2. Macrophage of peripheral blood
  3. Dendritic (plasmacytoid) cell
  4. Parotid gland
  5. Peritoneum
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Infestation by Ixodidae
  2. Turner syndrome
  3. Cutaneous acariasis
  4. Disorder of pregnancy
  5. Anomaly of chromosome X
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Demeclocycline
  2. Flupenthixol
  3. Pempidine
  4. Betahistine
  5. Tiapamil Hydrochloride
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. H2-Eb2
  2. MIR10A
  3. C15orf65
  4. ZYX
  5. CIITA
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. ATR phosphorylates DHX9 at serine 321 to suppress R-loop accumulation upon genotoxic stress.
  2. An underlying mechanism for MleR activating the malolactic enzyme pathway to enhance acid tolerance …
  3. DHX9 maintains epithelial homeostasis by restraining R-loop-mediated genomic instability in intestin…
  4. PARP1, DIDO3, and DHX9 Proteins Mutually Interact in Mouse Fibroblasts, with Effects on DNA Replicat…
  5. Targeting the DHX9 RNA Helicase to Induce Antitumor Immunity in Small-Cell Lung Cancer.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Modified Corneal EA With Middle LKP for Severe Corneal Burn
  2. Anticaries Effect of Probiotic Lactobacillus Brevis CD2 (Lb CD2).
  3. Immunotherapy With Durva and Treme With or Without Capecitabine in Adjuvant Treatment for Biliary Tr…
  4. Progression Rate of MSA Under EGCG Supplementation as Anti-Aggregation-Approach
  5. Fostering Efficacy of Anti - PD-1 - Treatment: Nivolumab Plus Radiotherapy in Advanced NSCLC
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.